STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
EVLO EVELO BIOSCIENCES INCORPORATED StockScouter® Report
4
StockScouter® Score
EVELO BIOSCIENCES INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The multi-period measure of relative price change and consistency is well above average. Positive
Concerns
- Moving average analysis for EVLO suggests weak price movement over the medium term. Negative
- Two or more executives, directors or major shareholders – including one high-level executive –sold a small number of shares recently. Very negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
C
D
N/A
B